Focus Issue: Exploring New Avenues for Cancer Treatment

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Science's STKE

• Publication date

  2007-04-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/STKE.3812007EG2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Excessive Angiogenesis Inhibits Tumor Growth

  2007cited by this paper
• Meeting Report: Targeting the Kinome—20 Years of Tyrosine Kinase Inhibitor Research in Basel

  2007cited by this paper
• EGFR Signaling Inhibits E2F1-Induced Apoptosis in Vivo: Implications for Cancer Therapy

  2007cited by this paper
• Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?

  2007cited by this paper
• Sequestration and Segregation of Receptor Kinases in Epithelial Cells: Implications for ErbB2 Oncogenesis

  2007cited by this paper
• Tumor Suppression by p53 Is Mediated in Part by the Antiangiogenic Activity of Endostatin and Tumstatin

  2006cited by this paper
• Focus Issue: Turning the Corner in Cancer Therapy?

  2006cited by this paper
• HIFing the Brakes: Therapeutic Opportunities for Treatment of Human Malignancies

  2006cited by this paper
• Notch Signaling Pathway

  2006cited by this paper
• PI3 Kinases in Cancer: From Oncogene Artifact to Leading Cancer Target

  2006cited by this paper
• Epithelial Barriers, Compartmentation, and Cancer

  2004cited by this paper
• Focus Issue: A Dangerous Detour–Cell Signaling Pathways Involved in Cancer Progression

  2004cited by this paper

• Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy

  2021cites this paper